Running Point Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.65M | Sell |
|
|||||
|
2025
Q2 | $1.79M | Sell |
|
|||||
|
2025
Q1 | $1.93M | Buy |
|
|||||
|
2024
Q4 | $1.43M | Buy |
|
|||||
|
2024
Q3 | $1.62M | Sell |
|
|||||
|
2024
Q2 | $1.68M | Sell |
|
|||||
|
2024
Q1 | $1.46M | Buy |
|
|||||
|
2023
Q4 | $598K | Buy |
|
|||||
|
2023
Q3 | $540K | Buy |
|
|||||
|
2023
Q2 | $468K | Buy |
|
|||||
|
2023
Q1 | $339K | Hold |
|
|||||
|
2022
Q4 | $361K | Buy |
|
|||||
|
2022
Q3 | $312K | Buy |
|
|||||
|
2022
Q2 | $285K | Buy |
|
|||||
|
2022
Q1 | $251K | Buy |
|
|||||
|
2021
Q4 | $238K | Buy |
|